about
Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescueARF functions as a melanoma tumor suppressor by inducing p53-independent senescenceHeterogeneous biomedical database integration using a hybrid strategy: a p53 cancer research database.Predicting positive p53 cancer rescue regions using Most Informative Positive (MIP) active learning.Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumorsCorrelation of IDH1 mutation with clinicopathologic factors and prognosis in primary glioblastoma: a report of 118 patients from Chinap53 Stabilization induces cell growth inhibition and affects IGF2 pathway in response to radiotherapy in adrenocortical cancer cellsSmall-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts.Chemotherapeutic approaches for targeting cell death pathways.Subchronic oral toxicity and metabolite profiling of the p53 stabilizing agent, CP-31398, in rats and dogsCancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides.Function of hyperekplexia-causing α1R271Q/L glycine receptors is restored by shifting the affected residue out of the allosteric signalling pathwayCP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice.p53 gene in treatment of hepatic carcinoma: status quo.The molecular genetics of breast cancer and targeted therapyFocal adhesion kinase and p53 signal transduction pathways in cancer.Sequential transcription factor targeting for diffuse large B-cell lymphomas.The transcriptional regulatory function of p53 is essential for suppression of mouse skin carcinogenesis and can be dissociated from effects on TGF-beta-mediated growth regulationp53 regulates FAK expression in human tumor cellsChoosing where to look next in a mutation sequence space: Active Learning of informative p53 cancer rescue mutants.Folding and misfolding mechanisms of the p53 DNA binding domain at physiological temperature.A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts.
P2860
Q27006998-5C5661DE-1292-408C-8754-63AD8F4264BCQ27680171-78366371-BE8C-48D2-83B5-20BF8A3B900FQ28591778-499E8DA0-2BC0-4355-8832-D0765AE74043Q30377322-F0D28F04-20E1-40FD-A069-54EF04B76E1DQ33503650-02FE9F8D-9B53-4F10-B8C8-E7F9DCFC9674Q34047882-21F93735-E680-4A05-A761-921896455D9BQ34146009-24F6ADCE-E3A6-4CA5-B38A-28335789CEB0Q34428159-B01D06A3-A8BF-4EB8-A590-F282956916DDQ34984251-BB9DAABA-D00C-4CE8-9998-CA55C3D7AE7CQ35094229-67D62590-EEBA-4F62-AE30-F19254C94D55Q35370602-C7E0D9F6-0FFE-4748-BF19-63315F10D90BQ35946185-B1449232-C2D4-4E46-A7BB-29D0562C0D2CQ36147271-3766C13E-6832-4DD3-9EC2-2098034A4B4DQ36173604-BD530C78-7EE9-4585-BA47-9BA8000A8C6AQ36764842-F6AE15A4-F1F5-42D8-AEC8-DD8895B69D37Q37290512-D561263C-2376-45A8-8EF9-71049B077889Q37761970-4CE48DE2-BD59-4B27-9E80-02A476574C16Q39320384-37551F69-B79A-413B-90E7-E58645A99C02Q39806153-4BCECD49-1003-44F4-A7C7-5D90DFBD47BFQ41835327-C632FA31-FFA1-4B32-9BA1-507AB18BA9EFQ42088464-C664B7E8-0C23-4220-8DF7-727B1743C326Q43043487-7C18D403-8AD0-4A84-BF54-7A00C846122DQ52722381-3018369D-D31B-4667-A02A-875ED1AFFA3D
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Restoring p53-dependent tumor suppression.
@ast
Restoring p53-dependent tumor suppression.
@en
type
label
Restoring p53-dependent tumor suppression.
@ast
Restoring p53-dependent tumor suppression.
@en
prefLabel
Restoring p53-dependent tumor suppression.
@ast
Restoring p53-dependent tumor suppression.
@en
P2093
P1476
Restoring p53-dependent tumor suppression.
@en
P2093
Farzan Rastinejad
Wafik S El-Deiry
Wenge Wang
P304
P433
P577
2003-07-01T00:00:00Z